An Open-Label, Multi-Center, Single Arm Study to Evaluate the Effects of Azilect on Sleep Disturbances in Parkinson's Disease Subjects.
Phase of Trial: Phase IV
Latest Information Update: 01 Nov 2016
At a glance
- Drugs Rasagiline (Primary)
- Indications Parkinson's disease
- Focus Therapeutic Use
- Acronyms REST
- Sponsors Teva Pharmaceutical Industries
- 14 Jul 2011 Actual end date (Jul 2011) added as reported by ClinicalTrials.gov.
- 14 Jul 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 28 Mar 2011 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.